Together, these pathways illuminate a sophisticated interplay between infection and tumor immune escape, emphasizing the therapeutic potential of targeting PD‐L1 with ICIs to counteract infection‐induced immune suppression and limit GC progression in H. pylori‐associated cases [56]. This evidence concerns the gene CD274 and neoplasm.